Mounjaro and SSRIs: Citalopram, Sertraline and Fluoxetine

The Mounjaro SmPC lists no specific interaction with SSRI antidepressants such as citalopram, sertraline or fluoxetine. The general point is that tirzepatide slows gastric emptying and can affect the absorption of oral medicines, most noticeably at the start, but SSRIs are not in the narrow-therapeutic-index group (like warfarin) that needs special monitoring. Both can cause nausea, so there may be some overlap. Never stop or change an antidepressant on your own; tell your prescriber all your medicines.

If you take an SSRI antidepressant such as citalopram, sertraline or fluoxetine and are considering Mounjaro, it is sensible to ask whether the two interact. The honest, corpus-based answer is that the medicine's licence does not list a specific interaction, but there are general points worth understanding, and one firm rule about not changing your antidepressant alone.

This guide sets out what the SmPC does and does not say about Mounjaro with SSRIs, the general absorption point, the overlap in side effects, and what to discuss with your prescriber. It draws on the UK Summary of Product Characteristics and the NHS. It is general information and not a substitute for advice about your own medicines.

Is there an interaction between Mounjaro and SSRIs?

Based on the licence, there is no specific listed interaction between tirzepatide and SSRI antidepressants such as citalopram, sertraline or fluoxetine ¹. The SmPC's interactions section does not name SSRIs as a class requiring particular caution or dose changes ¹.

This guide is careful not to invent an interaction that the evidence does not describe ¹. What the SmPC does set out is a general principle about how tirzepatide can affect oral medicines, covered next, which is the relevant consideration rather than an SSRI-specific warning ¹.

So the starting point is reassuring: no specific clash is documented ¹. The sections below explain the general absorption point, the side-effect overlap, and the important rule about not changing your antidepressant on your own ¹³.

It is worth saying why this matters for how you read other sources, too ¹. Searches about GLP-1 medicines and antidepressants can turn up alarming-sounding claims, but the corpus-based position from the licence is simply that no specific SSRI interaction is listed, and this guide deliberately stays on that ground rather than amplifying speculation ¹. That does not mean your individual situation needs no thought, only that the right place to get that thought is your prescriber, who can look at your particular medicines, rather than a generic warning ³.

What the SmPC actually says about other medicines

The general point in the SmPC is that tirzepatide delays gastric emptying, which can affect the rate of absorption of oral medicines taken at the same time, an effect that is most pronounced at the start of treatment and after dose increases ¹. In a study using paracetamol as a model, this changed how quickly it was absorbed but not the overall exposure ¹.

Crucially, the SmPC concludes that no dose adjustments are expected for most oral medicines, and singles out only narrow-therapeutic-index drugs such as warfarin and digoxin for monitoring, especially at initiation and after dose increases ¹. SSRIs are not in that narrow-therapeutic-index group ¹.

So the general consideration, a possible change in the speed of absorption around starting and dose increases, applies in principle, but the SmPC does not flag SSRIs as needing the special monitoring reserved for warfarin-type medicines ¹.

It also helps to understand what this absorption effect is and is not. It is about the rate at which a medicine is taken up, not necessarily the total amount: in the paracetamol model, the peak was lower and later but the overall exposure was unchanged, and after a few weeks of treatment even that effect on the peak had settled ¹. So the practical concern, where it exists, is mainly about the first weeks and dose increases rather than ongoing treatment, and it is most relevant for medicines where the timing of a peak level matters ¹. For an SSRI taken regularly for a steady effect, this kind of rate-of-absorption change is not the sort of thing the SmPC singles out as clinically important ¹.

Why SSRIs are not in the special-monitoring group

The reason warfarin and digoxin are singled out is that they have a narrow therapeutic index: small changes in their levels can matter clinically, so any effect on absorption is worth monitoring ¹. SSRIs do not have that same narrow margin in the way the SmPC describes, which is why they are not named for special monitoring ¹.

This does not mean absorption is irrelevant, but it does mean the SmPC does not call for the kind of routine monitoring it advises for warfarin ¹. The practical upshot is that the general principle is worth being aware of without it implying a specific problem for SSRIs ¹.

As always, your prescriber, who knows your full medicine list, is the right person to judge whether any individual consideration applies to your particular SSRI and dose ³.

Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.

Overlapping side effects

One genuinely useful thing to know is that both Mounjaro and SSRIs can cause nausea and other gastrointestinal upset, particularly when first started or when a dose changes ². So if you start Mounjaro while on an SSRI, some nausea could come from either, and the two effects may add together ².

Tirzepatide's gut effects are most prominent during dose escalation and then settle, and the usual measures, smaller meals, staying hydrated and a gradual dose build, help ². Our guide on managing nausea, bloating and constipation covers these.

If nausea is troublesome, it is worth mentioning to your prescriber that you take both, so they can consider which is contributing and how to manage it, rather than assuming it must be the Mounjaro ²³.

This overlap is also worth keeping in mind when you judge how you are tolerating Mounjaro early on ². If you were already used to your SSRI, any new nausea is more likely to be from the Mounjaro escalation, but if you happen to start both around the same time, the two can be hard to separate ². Either way, the gut effects of the escalation usually settle, and your prescriber can help work out the picture if it does not ²³.

Do not change your antidepressant on your own

This is the most important safety point on the page: do not stop or change your antidepressant in order to start or continue a weight-loss medicine, and do not adjust it on your own ³. Antidepressants are prescribed for a reason, and stopping them abruptly can cause problems of its own.

Any change to your mental-health medication is a decision for the prescriber who manages it, made with proper support, not something to fit around starting Mounjaro ³. The two treatments can be managed alongside each other with your prescribers aware of both ¹³.

If you have any concerns about your mood or mental health, that is a reason to speak to your doctor, who can help, rather than to make medication changes yourself ³. Continuity of your antidepressant treatment matters ³.

It is worth being explicit about why this rule deserves emphasis. Stopping an SSRI suddenly can cause unpleasant discontinuation effects and, more importantly, can risk a return of the symptoms it was treating, so it is never something to do casually or to fit around starting another medicine ³. The aim of taking a weight-loss medicine is to improve your health, and that goal is not served by destabilising mental-health treatment that is working ³. If your weight and your mood are both things you want to address, the sensible path is to keep both sets of prescribers informed and let them coordinate, rather than trading one treatment off against the other yourself ¹³.

What to discuss with your prescriber

Before starting Mounjaro, tell your prescriber about your SSRI and any other medicines, herbal remedies or supplements, as the NHS advises ³. This lets them check your full list and judge whether any individual consideration applies, even though no specific SSRI interaction is listed ¹³.

It is also worth flagging that both can cause nausea, so any plan for managing side effects takes both into account ². And reinforce with yourself the rule that your antidepressant stays as prescribed unless its prescriber advises otherwise ³.

Our guide on how Mounjaro works covers the medicine more broadly. The key message here is that the combination is not flagged as a specific interaction, but it is still something to manage with your prescriber fully informed ¹³. Informed coordination, not special handling, is what the combination calls for ¹.

Keeping both prescribers in the picture is the practical safeguard, since the person who manages your antidepressant and the person who prescribes your weight-loss treatment may not be the same, and each should know what the other has prescribed ³. That shared awareness, rather than any special monitoring requirement, is what keeps the combination managed sensibly ¹³.

Frequently asked questions

Can you take Mounjaro with citalopram, sertraline or fluoxetine?

The SmPC lists no specific interaction between tirzepatide and SSRI antidepressants such as citalopram, sertraline or fluoxetine ¹. The general point is that tirzepatide can affect the absorption of oral medicines, but SSRIs are not in the narrow-therapeutic-index group needing special monitoring ¹. Tell your prescriber all your medicines and never change an antidepressant on your own ³.

Does Mounjaro affect how SSRIs are absorbed?

Tirzepatide slows gastric emptying, which can affect the rate of absorption of oral medicines, most noticeably at the start and after dose increases ¹. However, the SmPC says no dose adjustment is expected for most oral medicines and singles out only narrow-therapeutic-index drugs like warfarin for monitoring, not SSRIs ¹.

Can taking Mounjaro and an SSRI together cause more nausea?

Possibly. Both can cause nausea and gut upset, especially when started or when a dose changes, so the effects may add together ². Tirzepatide's gut effects are usually worst during dose escalation and then settle ². If nausea is troublesome, tell your prescriber you take both so they can judge which is contributing ²³.

Should I stop my antidepressant to take Mounjaro?

No. Do not stop or change your antidepressant to start a weight-loss medicine, and do not adjust it on your own ³. Antidepressants are prescribed for a reason and stopping abruptly can cause problems. Any change is a decision for the prescriber who manages it, and the two can be managed alongside each other ³.

Is there a dangerous interaction between Mounjaro and SSRIs?

The SmPC does not list a specific interaction between tirzepatide and SSRIs, and this guide does not claim one ¹. The general absorption point applies but SSRIs are not flagged for special monitoring ¹. Your prescriber, knowing your full medicine list, is the right person to judge any individual consideration ³.

What should I tell my prescriber about my antidepressant?

Tell them which SSRI and dose you take, along with any other medicines, herbal remedies or supplements, as the NHS advises ³. This lets them check your full list, plan for any overlapping nausea, and confirm your antidepressant continues as prescribed ¹²³.

Your next step

The Mounjaro SmPC lists no specific interaction with SSRI antidepressants such as citalopram, sertraline or fluoxetine. The general point is that tirzepatide can affect the absorption of oral medicines around starting and dose increases, but SSRIs are not in the narrow-therapeutic-index group that needs special monitoring. Both can cause nausea, so there may be some overlap.

Tell your prescriber every medicine you take so they can judge any individual consideration, and plan for overlapping side effects. Most importantly, never stop or change your antidepressant on your own to fit around a weight-loss medicine; any change is for the prescriber who manages it, and if you have concerns about your mood, speak to your doctor. Managed this way, with both prescribers informed, an SSRI and Mounjaro can be taken alongside each other without the kind of special interaction handling that some other medicines require.

Disclaimer

This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.

If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.

If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.

References

1. 4.5 Interactions (delayed gastric emptying; no adjustment for most oral medicines; only narrow-therapeutic-index drugs like warfarin/digoxin monitored; no SSRI-specific interaction listed)
2. 4.8 Undesirable effects (nausea common/very common; worst during dose escalation)
3. Tirzepatide (tell your doctor about other medicines; do not stop medicines without advice)